Alyaa Ajabnoor
@alyaa_an
Assistant professor in pharmacoepidemiology @KAUpharmacy | Pharmacist | Alumni @OfficialUoM
ID: 321920719
https://www.linkedin.com/in/alyaa-ajabnoor-380008100 22-06-2011 10:39:19
122 Tweet
246 Takipçi
218 Takip Edilen
5/ Paper #1: What is a p-value anyway? Probably not what you think! In this paper, Greenland (Sander Greenland) et al. fight back against false interpretations of statistical tests, confidence intervals, and statistical power, one misconception at a time. link.springer.com/article/10.100…
Thanks to The BMJ for highlighting our study. Full-paper PLOS Medicine doi.org/10.1371/journa… #primarycare #bigdata #healthequity #cardiovascular UoM Primary Care Pharmacy DUPP The University of Manchester كلية الصيدلة بجامعة الملك عبدالعزيز x.com/bmj_latest/sta…
الترميز الطبي Medical Coding يعتبر علم بحد ذاته وله أهمية كبيرة في أي نظام صحي لإخراج بيانات صحيحة ودقيقة. أتمنى أن ينال هذا المجال أهمية من كل الجهات المتعلقة بالنظام الصحي سواء الحكومي أو الخاص. وزارة الصحة السعودية #الترميز_الطبي #coding #healthcare
Delighted to see our recent study picked up by the official journal of the Royal Pharmaceutical Society The Pharmaceutical Journal pharmaceutical-journal.com/article/news/d… Full study PLOS Medicine journals.plos.org/plosmedicine/a…
Our analysis led by Alyaa Ajabnoor using UK national data shows Oral anticoagulant prescribing among patients with cancer and atrial fibrillation in England is much less than in patients without cancer, esp haematological malignancies snd lung CA, even though these pts are at higher
Dr. Purvi Parwani Dr. Martha Gulati ♥️🫀❤️🩹🇨🇦 3. Alyaa Ajabnoor who undertook a PhD with Evan Kontopantelis and myself, has published many important papers around AF and its management in patients with cancer, aswell as Rosa Parisi and Σalwa Zghebi who have supported many of our works with methodology, and have involved me in theirs
Our new paper is out led by Evan Kontopantelis & an amazing team involving Mamas A. Mamas Prof.Ashcroft Σalwa Zghebi Rosa Parisi Corinne Faivre-Finn We have examined the performance of stroke and bleeding risk assessment scores in AF patient with certain types of cancer doi.org/10.1093/ehjope…
Our analysis led by Alyaa Ajabnoor studying Performance of CHA2DS2-VASc and HAS-BLED in predicting stroke and bleeding in atrial fibrillation and patients with cancer .European Society of Cardiology Journals ➡️ academic.oup.com/ehjopen/articl… 💥 CHA2DS2-VASc has similar discrimination in patients with and without